Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Plos Genetics|January 9, 2015
Functional interplay between the 53BP1-ortholog Rad9 and the Mre11 complex regulates resection, end-tethering and repair of a double-strand breakMatteo Ferrari, Diego Dibitetto, Giuseppe De Gregorio, et al.
Plos One|October 3, 2012
EZN-2208 (PEG-SN38) overcomes ABCG2-mediated topotecan resistance in BRCA1-deficient mouse mammary tumorsSerge A L Zander, Wendy Sol, Lee Greenberger, et al.
Mbio|May 15, 2024
TurboID mapping reveals the exportome of secreted intrinsically disordered proteins in the transforming parasite Theileria annulataFrancis Brühlmann, Carmen Perry, Charlotte Griessen, et al.
The Journal of Cell Biology|February 24, 2017
TOPBP1Dpb11 plays a conserved role in homologous recombination DNA repair through the coordinated recruitment of 53BP1Rad9Yi Liu, José Renato Cussiol, Diego Dibitetto, et al.
Veterinary and Comparative Oncology|December 30, 2022
Organoids of patient-derived medullary thyroid carcinoma: The first milestone towards a new in vitro model in dogsStephanie Scheemaeker, Marine Inglebert, Sylvie Daminet, et al.
The AAPS Journal|November 26, 2015
Development of a Tumour Growth Inhibition Model to Elucidate the Effects of Ritonavir on Intratumoural Metabolism and Anti-tumour Effect of Docetaxel in a Mouse Model for Hereditary Breast CancerHuixin Yu, Jeroen J M A Hendrikx, Sven Rottenberg, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 7, 2012
Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrolSerge A L Zander, Ariena Kersbergen, Wendy Sol, et al.
Cancer Research|August 6, 2009
Moderate increase in Mdr1a/1b expression causes in vivo resistance to doxorubicin in a mouse model for hereditary breast cancerMarina Pajic, Jayasree K Iyer, Ariena Kersbergen, et al.
Cancer Research|December 17, 2014
BRCA2-deficient sarcomatoid mammary tumors exhibit multidrug resistanceJanneke E Jaspers, Wendy Sol, Ariena Kersbergen, et al.
Nature Communications|May 24, 2024
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumoursDiego Dibitetto, Martin Liptay, Francesca Vivalda, et al.
Pageof 13